|
DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM). |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Spectrum Pharmaceuticals; Takeda |
Research Funding - Amgen (Inst); Janssen Oncology (Inst); Takeda (Inst) |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie |
Consulting or Advisory Role - Celgene |
Research Funding - BiolineRx; GlaxoSmithKline; Janssen; Takeda |
Other Relationship - Cellerant |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda |
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pharmamar-zeltia; Takeda |
|
|
Honoraria - Amgen; Celgene; Janssen |
Consulting or Advisory Role - Amgen; Celgene; Janssen |
|
Travel, Accommodations, Expenses - Novartis |
|
|
Stock and Other Ownership Interests - Adaptimmune; Aprea AB; Bellicum Pharmaceuticals; Cell Therapeutics; Cellectis; crispr therapeutics; Editas Medicine; Geron; idera; Intellia Therapeutics; Jounce Therapeutics; MEI Pharma; Nektar; Sangamo Therapeutics; Sorrento Therapeutics; TG Therapeutics; TG Therapeutics |
Consulting or Advisory Role - Foundation Medicine |
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Sirtex Medical; verastem |
Travel, Accommodations, Expenses - Nektar |
|
|
Consulting or Advisory Role - Celgene; Janssen Oncology; Takeda |
Research Funding - Janssen (Inst) |
|
|
Employment - GlaxoSmithKline UK Ltd. |
Stock and Other Ownership Interests - GlaxoSmithKline UK Ltd.; Roche |
Research Funding - GlaxoSmithKline UK Ltd. |
|
|
Employment - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
Research Funding - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Honoraria - Celgene; GlaxoSmithKline; Janssen; Takeda |
Consulting or Advisory Role - Abbvie; Celgene; GlaxoSmithKline; Takeda |
Research Funding - Takeda (Inst) |
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Takeda |